Maintenance Notice (4:00 AM - 1:30 PM January 5, 2025): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197 | New tool "TCI SpectraViewer" | [Product Highlights] o-Nitrobenzyl Photolabile... | Product Document Searching Made Easy by 2D Code!
Maximum quantity allowed is 999
CAS RN: 2438-72-4 | Product Number: B4179
Bufexamac
Purity: >98.0%(HPLC)
- 2-(4-Butoxyphenyl)acetohydroxamic Acid
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
5G |
₹4,800.00
|
2 | ≥60 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | B4179 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__1__2H__1__7NO__3 = 223.27 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
CAS RN | 2438-72-4 |
Reaxys Registry Number | 2646848 |
PubChem Substance ID | 253662254 |
Merck Index (14) | 1474 |
MDL Number | MFCD00078936 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Neutralization titration) | min. 97.0 % |
Melting Point | 164 °C(dec.) |
Solubility in water | Insoluble |
Pictogram | |
Signal Word | Warning |
Hazard Statements | H317 : May cause an allergic skin reaction. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P261 : Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P272 : Contaminated work clothing should not be allowed out of the workplace. P280 : Wear protective gloves. P302 + P352 : IF ON SKIN: Wash with plenty of water. P362 + P364 : Take off contaminated clothing and wash it before reuse. P333 + P313 : If skin irritation or rash occurs: Get medical advice/ attention. |
RTECS# | AK8280000 |
References
- Bufexamac (a review)
- M. Alhadeff, Drugs Today 1976, 12, 435.
- Examinations of the antioxidative properties of the topically administered drug bufexamac reveal new insights into its mechanism of action
- Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.